Envol Biomedical Advisor; Founder, Mammoth Preclinical Consulting, LLC.
Envol Biomedical/ Mammoth Preclinical Consulting, LLC.
Placitas, New Mexico
C. Edwin Garner, Ph.D., the founder of Mammoth Preclinical Consulting, has diverse cross functional experience from over 25 years in large pharma, start ups, and basic research in xenobiotic metabolism and pharmacokinetics. Dr Garner is an expert in pharmacokinetic and PBPK modeling/simulation based translation of preclinical PK and PD to clinical environment. He has contributed to discovery and development in numerous therapeutic areas in small and large molecule space including nanoparticulates, antibodies, prodrugs, protein-oligonucleotide constructs, oligonucleotides and gene therapies. He provides support in the planning, executing, and analyzing in vitro and in vivo nonclinical studies in preclinical PBPK/ADME, toxicology and pharmacology disciplines via domestic and international outsourcing. He has provided strategic planning, execution, direction of drug discovery and development programs from lead optimization, through nonclinical IND enabling studies and Phase 1/2. Dr Garner is the author of >100 peer reviewed publications and abstracts. He has contributed to multiple PINDs and INDs, and had direct interaction with regulatory agencies. Dr Garner is an Adjunct Assistant Professor at University of Colorado-Anschutz Department of Pharmaceutical Sciences and Vice President, Modeling and Simulation at Resero Analytics.
Disclosure information not submitted.
Tuesday, October 22, 2024
2:00 PM – 3:00 PM MT